Table 1 Univariate and multivariate analysis of different prognostic factors for overall survival in patients with LUAD.
Characteristics | Total patients(n,%) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
OS HR (95% CI) | P-value | OS HR (95% CI) | P-value | ||
Gender | Â | Â | Â | Â | Â |
Male | 48 (53.3%) | Reference | Â | Â | Â |
Female | 42 (46.7%) | 0.885(0.528–1.484) | 0.644 |  |  |
Age,year | Â | Â | Â | Â | Â |
<60 | 40 (44.4%) | Reference | Â | Â | Â |
≥60 | 50 (55.6%) | 1.476(0.868–2.510) | 0.150 |  |  |
T stage | Â | Â | Â | Â | Â |
T1-2 | 80 (88.9%) | Reference | Â | Â | Â |
T3-4 | 10 (11.1%) | 3.473(1.666–7.238) | 0.004 | 3.246 (1.329–7.928) | 0.010 |
N stage | Â | Â | Â | Â | Â |
Negative | 56 (62.2%) | Reference | Â | Â | Â |
Positive | 34 (37.8%) | 1.558(0.917–2.645) | 0.101 |  |  |
Clinical stage | Â | Â | Â | Â | Â |
I -II | 70 (77.8%) | Reference | Â | Â | Â |
III-IV | 20 (22.2%) | 2.482 (1.382–4.460) | 0.002 | 1.251 (0.593–2.639) | 0.556 |
Histologic grades | Â | Â | Â | Â | Â |
1–2 | 69 (76.7%) | Reference |  |  |  |
3 | 21 (23.3%) | 2.064(1.164–3.659) | 0.013 | 1.282 (0.673–2.444) | 0.450 |
TMEM9 | Â | Â | Â | Â | Â |
Low | 45 (50%) | Reference | Â | Â | Â |
High | 45 (50%) | 2.286(1.340–3.901) | 0.002 | 5.925 (3.212–10.929) | 0.001 |